Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
Background: Overexpression of the transsulfuration enzyme cystathionine-β-synthase (CBS), and overproduction of its product, hydrogen sulfide (H2S) are recognized as potential pathogenetic factors in Down syndrome (DS). The purpose of the study was to determine how the mitochondrial function and cor...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231722001884 |
_version_ | 1798042475465539584 |
---|---|
author | Theodora Panagaki Laszlo Pecze Elisa B. Randi Anni I. Nieminen Csaba Szabo |
author_facet | Theodora Panagaki Laszlo Pecze Elisa B. Randi Anni I. Nieminen Csaba Szabo |
author_sort | Theodora Panagaki |
collection | DOAJ |
description | Background: Overexpression of the transsulfuration enzyme cystathionine-β-synthase (CBS), and overproduction of its product, hydrogen sulfide (H2S) are recognized as potential pathogenetic factors in Down syndrome (DS). The purpose of the study was to determine how the mitochondrial function and core metabolic pathways are affected by DS and how pharmacological inhibition of CBS affects these parameters. Methods: 8 human control and 8 human DS fibroblast cell lines have been subjected to bioenergetic and fluxomic and proteomic analysis with and without treatment with a pharmacological inhibitor of CBS. Results: DS cells exhibited a significantly higher CBS expression than control cells, and produced more H2S. They also exhibited suppressed mitochondrial electron transport and oxygen consumption and suppressed Complex IV activity, impaired cell proliferation and increased ROS generation. Inhibition of H2S biosynthesis with aminooxyacetic acid reduced cellular H2S, improved cellular bioenergetics, attenuated ROS and improved proliferation. 13C glucose fluxomic analysis revealed that DS cells exhibit a suppression of the Krebs cycle activity with a compensatory increase in glycolysis. CBS inhibition restored the flux from glycolysis to the Krebs cycle and reactivated oxidative phosphorylation. Proteomic analysis revealed no CBS-dependent alterations in the expression level of the enzymes involved in glycolysis, oxidative phosphorylation and the pentose phosphate pathway. DS was associated with the dysregulation of several components of the autophagy network; CBS inhibition normalized several of these parameters. Conclusions: Increased H2S generation in DS promotes pseudohypoxia and contributes to cellular metabolic dysfunction by causing a shift from oxidative phosphorylation to glycolysis. |
first_indexed | 2024-04-11T22:36:02Z |
format | Article |
id | doaj.art-b0becb51c84d4deebe6c55969415c4fb |
institution | Directory Open Access Journal |
issn | 2213-2317 |
language | English |
last_indexed | 2024-04-11T22:36:02Z |
publishDate | 2022-09-01 |
publisher | Elsevier |
record_format | Article |
series | Redox Biology |
spelling | doaj.art-b0becb51c84d4deebe6c55969415c4fb2022-12-22T03:59:12ZengElsevierRedox Biology2213-23172022-09-0155102416Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndromeTheodora Panagaki0Laszlo Pecze1Elisa B. Randi2Anni I. Nieminen3Csaba Szabo4Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandFaculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandFaculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandMetabolomics Unit, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, FinlandFaculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Corresponding author. Faculty of Science and Medicine, University of Fribourg, Ch. du Musée 18, Fribourg, 1700, Switzerland.Background: Overexpression of the transsulfuration enzyme cystathionine-β-synthase (CBS), and overproduction of its product, hydrogen sulfide (H2S) are recognized as potential pathogenetic factors in Down syndrome (DS). The purpose of the study was to determine how the mitochondrial function and core metabolic pathways are affected by DS and how pharmacological inhibition of CBS affects these parameters. Methods: 8 human control and 8 human DS fibroblast cell lines have been subjected to bioenergetic and fluxomic and proteomic analysis with and without treatment with a pharmacological inhibitor of CBS. Results: DS cells exhibited a significantly higher CBS expression than control cells, and produced more H2S. They also exhibited suppressed mitochondrial electron transport and oxygen consumption and suppressed Complex IV activity, impaired cell proliferation and increased ROS generation. Inhibition of H2S biosynthesis with aminooxyacetic acid reduced cellular H2S, improved cellular bioenergetics, attenuated ROS and improved proliferation. 13C glucose fluxomic analysis revealed that DS cells exhibit a suppression of the Krebs cycle activity with a compensatory increase in glycolysis. CBS inhibition restored the flux from glycolysis to the Krebs cycle and reactivated oxidative phosphorylation. Proteomic analysis revealed no CBS-dependent alterations in the expression level of the enzymes involved in glycolysis, oxidative phosphorylation and the pentose phosphate pathway. DS was associated with the dysregulation of several components of the autophagy network; CBS inhibition normalized several of these parameters. Conclusions: Increased H2S generation in DS promotes pseudohypoxia and contributes to cellular metabolic dysfunction by causing a shift from oxidative phosphorylation to glycolysis.http://www.sciencedirect.com/science/article/pii/S2213231722001884Down syndromeMetabolismOxidative phosphorylationGlycolysisHydrogen sulfide |
spellingShingle | Theodora Panagaki Laszlo Pecze Elisa B. Randi Anni I. Nieminen Csaba Szabo Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome Redox Biology Down syndrome Metabolism Oxidative phosphorylation Glycolysis Hydrogen sulfide |
title | Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome |
title_full | Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome |
title_fullStr | Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome |
title_full_unstemmed | Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome |
title_short | Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome |
title_sort | role of the cystathionine β synthase h2s pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome |
topic | Down syndrome Metabolism Oxidative phosphorylation Glycolysis Hydrogen sulfide |
url | http://www.sciencedirect.com/science/article/pii/S2213231722001884 |
work_keys_str_mv | AT theodorapanagaki roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome AT laszlopecze roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome AT elisabrandi roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome AT anniinieminen roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome AT csabaszabo roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome |